L
Leslee J. Shaw
Researcher at Cornell University
Publications - 871
Citations - 70793
Leslee J. Shaw is an academic researcher from Cornell University. The author has contributed to research in topics: Coronary artery disease & Myocardial infarction. The author has an hindex of 116, co-authored 808 publications receiving 61598 citations. Previous affiliations of Leslee J. Shaw include Saint Louis University & Cedars-Sinai Medical Center.
Papers
More filters
Journal ArticleDOI
Association of Body Mass Index With Coronary Artery Calcium and Subsequent Cardiovascular Mortality: The Coronary Artery Calcium Consortium.
Joseph C. Jensen,Zeina Dardari,Michael J. Blaha,Susan White,Leslee J. Shaw,John A. Rumberger,Alan Rozanski,Daniel S. Berman,Matthew J. Budoff,Khurram Nasir,Michael D. Miedema +10 more
TL;DR: In a large sample undergoing CAC scoring, obesity was associated with a higher risk of CAC and subsequent coronary heart disease, CVD, and all-cause mortality, however, overweight individuals did not have aHigher risk of mortality despite a higherrisk for CAC.
Journal ArticleDOI
Coronary Artery Calcium and the Age-Specific Competing Risk of Cardiovascular Versus Cancer Mortality: The Coronary Artery Calcium Consortium
Seamus P. Whelton,Mahmoud Al Rifai,Catherine Handy Marshall,Zeina Dardari,Leslee J. Shaw,Mouaz H. Al-Mallah,Alan Rozanski,Martin Bødtker Mortensen,Omar Dzaye,Lydia A. Bazzano,Tanika N. Kelly,Kunihiro Matsushita,John A. Rumberger,Daniel S. Berman,Matthew J. Budoff,Michael D. Miedema,Khurram Nasir,Khurram Nasir,Michael J. Blaha +18 more
TL;DR: The authors' age-specific estimate for the coronary artery calcium score at which cardiovascular disease overtakes cancer mortality allows for a more precise approach to synergistic prediction and prevention strategies for cardiovascular disease and cancer.
Journal ArticleDOI
Long-term prognostic utility of computed tomography coronary angiography in older populations
S. Gnanenthiran,Christopher Naoum,Jonathon Leipsic,Stephan Achenbach,Mouaz H. Al-Mallah,Daniele Andreini,Jeroen J. Bax,Daniel S. Berman,Matthew J. Budoff,Filippo Cademartiri,Tracy Q. Callister,Hyuk Jae Chang,Kavitha Chinnaiyan,Benjamin J.W. Chow,Ricardo C. Cury,Augustin Delago,Gudrun Feuchtner,Martin Hadamitzky,Joerg Hausleiter,Philipp A. Kaufman,Yong Jin Kim,Erica Maffei,Hugo Marques,Pedro de Araújo Gonçalves,Gianluca Pontone,Gilbert L. Raff,Ronen Rubinshtein,Leslee J. Shaw,Todd C. Villines,Heidi Gransar,Yao Lu,Erica C. Jones,Jessica M. Peña,Fay Y. Lin,Leonard Kritharides,James K. Min +35 more
TL;DR: The presence and extent of CAD is a meaningful stratifier of long-term mortality and MACE in patients aged <70 years and ≥70 years old and the presence of obstructive and non-obstructive disease and the burden of atherosclerosis determined by SIS remain important predictors of prognosis in older populations.
Journal ArticleDOI
Impact of age on coronary artery plaque progression and clinical outcome: A PARADIGM substudy.
Minkwan Kim,Seung Pyo Lee,Soongu Kwak,Seokhun Yang,Yong Jin Kim,Daniele Andreini,Mouaz H. Al-Mallah,Matthew J. Budoff,Filippo Cademartiri,Kavitha Chinnaiyan,Jung Hyun Choi,Edoardo Conte,Hugo Marques,Pedro de Araújo Gonçalves,Ilan Gottlieb,Martin Hadamitzky,Jonathon Leipsic,Erica Maffei,Gianluca Pontone,Gilbert L. Raff,Sanghoon Shin,Byoung Kwon Lee,Eun Ju Chun,Ji Min Sung,Sang Eun Lee,Daniel S. Berman,Fay Y. Lin,Renu Virmani,Habib Samady,Peter Stone,Jagat Narula,Jeroen J. Bax,Leslee J. Shaw,James K. Min,Hyuk Jae Chang +34 more
TL;DR: Age is a significant factor in plaque growth, the importance of which is comparable to other traditional risk factors, and the rate of whole-heart plaque progression and dense calcification increases depending on age.
Journal ArticleDOI
Utility of novel serum biomarkers to predict subclinical atherosclerosis: A sub-analysis of the EISNER study.
Shuktika Nandkeolyar,Ali Naqvi,Wenjun Fan,Ajay N. Sharma,Jamal S. Rana,Alan Rozanski,Leslee J. Shaw,John D. Friedman,Sean W. Hayes,Damini Dey,Nathan D. Wong,Daniel S. Berman +11 more
TL;DR: OPN identifies progression of atherosclerosis in persons free of ASCVD at baseline and may be a useful predictive tool to guide ASCVD prevention management.